Ultrasound could make a common vein procedure safer and faster

NCT ID NCT07701746

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Sep 03, 2026 · Updated 3 times

Summary

This trial compares two methods for inserting a central line into the internal jugular vein: using ultrasound guidance versus the traditional landmark technique. The study measures how many needle adjustments are needed, first-attempt success, and total time to access the vein. Results may help determine which approach is more efficient and less risky for patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound guidance
What this could lead to
If ultrasound proves better, it could become the standard method for this common procedure, reducing complications and improving patient safety.
What could go wrong
This is a single-center study with a moderate number of participants, so results may not apply everywhere. The landmark technique is already widely used and effective in experienced hands.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of patients aged 18 to 75 years who are scheduled to undergo surgery in the general operating room unit at Dicle University Faculty of Medicine Hospital and require the insertion of a central venous catheter. All included patients will receive standard general anesthesia following an 8-hour fasting period

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-75 years * Patients operated on in the general operating room unit * Patients undergoing central venous catheter insertion Exclusion Criteria: * Refusal to participate in the study * Patients aged under 18 or over 75 years * Patients undergoing emergency surgery * Presence of coagulopathy * History of infection, operation, or cannulation in the intervention area * Allergy to USG gel

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central vein catheter are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dicle University

    Diyarbakır, Eyalet/Yerleşke, 21070, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.